On August 13th, the CDC issued a statement recommending that people who are moderately to severely immunocompromised receive an additional dose of mRNA COVID-19 vaccine after the initial 2 doses. The CDC defines moderately to severely immunocompromised individuals as those who have:
- Been receiving active cancer treatment for tumors or cancers of the blood
- Received an organ transplant and are taking medicine to suppress the immune system
- Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
- Advanced or untreated HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response (including biologics such as Enbrel, Humira and Remicade)
Individuals should talk to their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them. For moderately to severely immunocompromised people, the third dose should be given at least 28 days after the completion of your initial mRNA COVID-19 vaccine series. You will need to attest that you qualify for the third dose of the vaccine, but a doctor’s note or order is not needed to receive it.